tiprankstipranks
Trending News
More News >
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
US Market

Aligos Therapeutics (ALGS) Income Statement

Compare
275 Followers

Aligos Therapeutics Income Statement

Last quarter (Q4 2025), Aligos Therapeutics's total revenue was $169.00K, a decrease of -73.13% from the same quarter last year. In Q4, Aligos Therapeutics's net income was $-19.88M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.19M$ 3.94M$ 15.53M$ 13.91M$ 4.36M
Gross Profit
$ 1.26M$ 3.94M$ 15.53M$ 13.91M$ 4.36M
Operating Expenses
$ 89.24M$ 93.10M$ 103.66M$ 111.49M$ 132.68M
Depreciation and Amortization
$ 930.00K$ 2.62M$ 3.07M$ 3.67M$ 3.78M
EBITDA
$ -87.06M$ -86.53M$ -85.06M$ -93.91M$ -124.54M
Operating Income
$ -87.98M$ -89.15M$ -88.13M$ -97.58M$ -128.32M
Other Income/Expenses
$ 64.11M$ -41.73M$ 1.24M$ 1.64M$ 132.00K
Pretax Income
$ -23.88M$ -130.88M$ -86.88M$ -95.94M$ -128.19M
Net Income
$ -24.19M$ -131.21M$ -87.68M$ -96.05M$ -128.33M
Per Share Metrics
Basic EPS
$ -2.45$ -20.94$ -3.52$ -2.25$ -3.22
Diluted EPS
$ -2.45$ -20.94$ -3.52$ -2.25$ -3.22
Weighted Average Shares Outstanding
9.88M 6.26M 24.87M 42.70M 39.86M
Weighted Average Shares Outstanding (Diluted)
9.88M 6.26M 24.87M 42.70M 39.86M
Currency in USD

Aligos Therapeutics Earnings and Revenue History